Cargando…

First-episode psychosis: How long does it last? A review of evolution and trajectory

Study of first-episode psychosis (FEP), an episode of psychotic nature which manifests for the first time in an individual in the longitudinal continuum of his/her illness, has been study matter of research interest in recent years. A comprehensive review of the literature will help us understand th...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Jyoti, Chatterjee, K., Srivastava, K., Chauhan, V. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709526/
https://www.ncbi.nlm.nih.gov/pubmed/35017801
http://dx.doi.org/10.4103/ipj.ipj_38_21
_version_ 1784622957070385152
author Prakash, Jyoti
Chatterjee, K.
Srivastava, K.
Chauhan, V. S.
author_facet Prakash, Jyoti
Chatterjee, K.
Srivastava, K.
Chauhan, V. S.
author_sort Prakash, Jyoti
collection PubMed
description Study of first-episode psychosis (FEP), an episode of psychotic nature which manifests for the first time in an individual in the longitudinal continuum of his/her illness, has been study matter of research interest in recent years. A comprehensive review of the literature will help us understand the evolution and trajectory of this concept better. A literature review of available articles addressing the concept, phenomenology, evolution, identification, course, and outcome of FEP was done; the same was subsequently divided into broad topics for better clarity and analyzed. FEP constituted a clinical psychotic phenomenon with underlying significant heterogeneity in diagnosis, stability, course, and outcome. The study has attempted to view FEP both as horizontal spectrum across various diagnoses and longitudinally ranging from asymptomatic individual with unknown risk status to attenuated psychosis to multiple relapses/unremitting illness. Many risk and protective factors have been brought out with varying certainty ranging bio-psycho-social spectrum. Efforts have been made to calculate polygenic risk score based on genes involvement/sharing between various psychotic spectrum disorders; as well as biomarker panels to identify people at risk. FEP may prove to be an important concept to understand psychosis in general; without putting things into the diagnostic rubric. It may help understand multiple risk and protective factors for the course and outcome of psychotic illness and may clear the cloud to sharpen the evidence toward commonality and distinctiveness between various psychotic diagnoses in vogue for more comprehensive concept.
format Online
Article
Text
id pubmed-8709526
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87095262022-01-10 First-episode psychosis: How long does it last? A review of evolution and trajectory Prakash, Jyoti Chatterjee, K. Srivastava, K. Chauhan, V. S. Ind Psychiatry J Review Article Study of first-episode psychosis (FEP), an episode of psychotic nature which manifests for the first time in an individual in the longitudinal continuum of his/her illness, has been study matter of research interest in recent years. A comprehensive review of the literature will help us understand the evolution and trajectory of this concept better. A literature review of available articles addressing the concept, phenomenology, evolution, identification, course, and outcome of FEP was done; the same was subsequently divided into broad topics for better clarity and analyzed. FEP constituted a clinical psychotic phenomenon with underlying significant heterogeneity in diagnosis, stability, course, and outcome. The study has attempted to view FEP both as horizontal spectrum across various diagnoses and longitudinally ranging from asymptomatic individual with unknown risk status to attenuated psychosis to multiple relapses/unremitting illness. Many risk and protective factors have been brought out with varying certainty ranging bio-psycho-social spectrum. Efforts have been made to calculate polygenic risk score based on genes involvement/sharing between various psychotic spectrum disorders; as well as biomarker panels to identify people at risk. FEP may prove to be an important concept to understand psychosis in general; without putting things into the diagnostic rubric. It may help understand multiple risk and protective factors for the course and outcome of psychotic illness and may clear the cloud to sharpen the evidence toward commonality and distinctiveness between various psychotic diagnoses in vogue for more comprehensive concept. Wolters Kluwer - Medknow 2021 2021-07-20 /pmc/articles/PMC8709526/ /pubmed/35017801 http://dx.doi.org/10.4103/ipj.ipj_38_21 Text en Copyright: © 2021 Industrial Psychiatry Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Prakash, Jyoti
Chatterjee, K.
Srivastava, K.
Chauhan, V. S.
First-episode psychosis: How long does it last? A review of evolution and trajectory
title First-episode psychosis: How long does it last? A review of evolution and trajectory
title_full First-episode psychosis: How long does it last? A review of evolution and trajectory
title_fullStr First-episode psychosis: How long does it last? A review of evolution and trajectory
title_full_unstemmed First-episode psychosis: How long does it last? A review of evolution and trajectory
title_short First-episode psychosis: How long does it last? A review of evolution and trajectory
title_sort first-episode psychosis: how long does it last? a review of evolution and trajectory
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709526/
https://www.ncbi.nlm.nih.gov/pubmed/35017801
http://dx.doi.org/10.4103/ipj.ipj_38_21
work_keys_str_mv AT prakashjyoti firstepisodepsychosishowlongdoesitlastareviewofevolutionandtrajectory
AT chatterjeek firstepisodepsychosishowlongdoesitlastareviewofevolutionandtrajectory
AT srivastavak firstepisodepsychosishowlongdoesitlastareviewofevolutionandtrajectory
AT chauhanvs firstepisodepsychosishowlongdoesitlastareviewofevolutionandtrajectory